Shak Lakhani
Avro Life Science CEO
Waterloo, Ontario
Shak is CEO and co-founder of Avro Life Science, a venture backed preclinical stage biotech startup. His academic background stems from tissue engineering research for biomaterials development and early organoid technology at University of Toronto, followed by nanomedicine at the University of Waterloo, and supplemented with business leadership experience gained from participation in Y-Combinator, the Creative Destruction Lab, and the Thiel Fellowship.
Avro’s novel delivery platform redefines the skin's potential as a therapeutic pathway, enabling the localized and systemic delivery of emerging medicines for neurology, dermatology, immunology and more.
avrolifesci.com
